Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Current IST-Free/Relapse-Free Survival As a Surrogate Estimate of OS after Allotransplant for Acute Leukemia

Roberto Crocchiolo, MD PhD, Alessio Signori, Mohamad Sobh, Hélène Labussière, Myriam Renault, Fiorenza Barraco, MD, Franck Emmanuel Nicolini, MD PhD, Mauricette Michallet, MD PhD

Blood (2017) 130 (Supplement 1): 2047.

https://doi.org/10.1182/blood.V130.Suppl_1.2047.2047

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone

Roberto Crocchiolo, MD, PhD, Barbara Sarina, MD, Stefania Bramanti, MD, Lucio Morabito, MD, Andrea Rimondo, Monica Balzarotti, Massimo Magagnoli, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Luca Castagna

Blood (2015) 126 (23): 2034.

https://doi.org/10.1182/blood.V126.23.2034.2034

Published: 2015

Journal Articles

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients

Blood (2015) 126 (23): 4401.

https://doi.org/10.1182/blood.V126.23.4401.4401

Published: 2015

Journal Articles

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Roberto Crocchiolo, MD PhD, Luca Castagna, MD, Sabine Fuerst, MD, Jean El Cheikh, MD, Barbara Sarina, MD, Stefania Bramanti, Angela Granata, MD, Lucio Morabito, MD, Laura Giordano, MD, Sylvain Garciaz, MD, Diane Coso, MD, Reda Bouabdallah, MD, Monica Balzarotti, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD PhD

Blood (2014) 124 (21): 3863.

https://doi.org/10.1182/blood.V124.21.3863.3863

Published: 2014

Journal Articles

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Luca Castagna, Stefania Bramanti, MD, Sabine Furst, Barbara Sarina, MD, Roberto Crocchiolo, MD PhD, Laura Giordano, MD, Jean El Cheikh, MD, Angela Granata, MD, Lucio Morabito, MD, Elisa Mauro, MD, Catherine Faucher, Bilal Mothy, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD

Blood (2014) 124 (21): 3902.

https://doi.org/10.1182/blood.V124.21.3902.3902

Published: 2014

Journal Articles

Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in High Risk Haematological Diseases: A 10-Years Evaluation at San Raffaele Scientific Institute

Blood (2014) 124 (21): 2498.

https://doi.org/10.1182/blood.V124.21.2498.2498

Published: 2014

Journal Articles

Higher Prevalence But Similar Infectious Profile Overtime After Haploidentical Transplantation Compared With HLA-Identical Transplantation For Hematological Diseases

Roberto Crocchiolo, MD, PhD, Luca Castagna, MD, Andrea Vai, Barbara Sarina, MD, Stefania Bramanti, MD, Elisa Mauro, Carmelo Carlo-Stella, MD, Armando Santoro, MD

Blood (2013) 122 (21): 4528.

https://doi.org/10.1182/blood.V122.21.4528.4528

Published: 2013

Journal Articles

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

Raynier Devillier, MD, Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Samia Harbi, Luca Castagna, Jean El Cheikh, MD, Angela Granata, Catherine Faucher, MD, Anne Marie Stoppa, Bilal Mohty, MD, Thomas Prebet, MD, PhD, Diane Coso, MD, Jerome Rey, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Didier Blaise, MD

Blood (2013) 122 (21): 3364.

https://doi.org/10.1182/blood.V122.21.3364.3364

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Raynier Devillier, MD, Luca Castagna, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Samia Harbi, Jean El Cheikh, MD, Angela Granata, Bilal Mohty, MD, Catherine Faucher, MD, Didier Blaise, MD

Blood (2013) 122 (21): 2139.

https://doi.org/10.1182/blood.V122.21.2139.2139

Published: 2013

Journal Articles

Lower Relapse and Better PFS Among Chemosensitive Patients Undergoing Allogeneic Transplantation By Haploidentical Compared With HLA-Identical DONOR: Results On A Cohort Of 94 Patients With Hodgkin’S Lymphoma

Luca Castagna, MD, Roberto Crocchiolo, MD, PhD, Stefania Bramanti, MD, Sabine Furst, MD, Barbara Sarina, MD, Jean El Cheikh, MD, Angela Granata, Raynier Devillier, MD, Sylvain Garciaz, MD, Reda Bouabdallah, MD, Armando Santoro, MD, Didier Blaise

Blood (2013) 122 (21): 2144.

https://doi.org/10.1182/blood.V122.21.2144.2144

Published: 2013

Journal Articles

Bone Marrow (BM) Versus Peripheral Blood Stem Cell (PBSC) For Haploidentical Transplantation With Nonmyeloblative (NMA) Conditioning Regimen and Post Infusion Cyclophosphamide

Luca Castagna, MD, Roberto Crocchiolo, MD, PhD, Sabine Furst, MD, Stefania Bramanti, Barbara Sarina, MD, Jean El-Cheikh, Samia Harbi, Angela Granata, Elisa Mauro, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise

Blood (2013) 122 (21): 2119.

https://doi.org/10.1182/blood.V122.21.2119.2119

Published: 2013

Journal Articles

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Lara Crucitti, MD, Roberto Crocchiolo, MD, PhD, Cristina Toffalori, PhD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Matteo Carrabba, MD, Benedetta Mazzi, BSc, Elisabetta Zino, BSc, Sarah Marktel, MD, Magda Marcatti, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 918.

https://doi.org/10.1182/blood.V122.21.918.918

Published: 2013

Journal Articles

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

Roberto Crocchiolo, MD PhD, Sabine Fuerst, MD, Jean El-Cheikh, MD PhD, Angela Granata, Claire Oudin, Geoffroy Venton, Norbert Vey, Reda Bouabdallah, MD, Anne Marie Stoppa, Florence Broussais, MD, Aude Charbonnier, MD, PhD, Claude Lemarie, Diane Coso, MD, Thomas Prebet, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3029.

https://doi.org/10.1182/blood.V120.21.3029.3029

Published: 2012

Journal Articles

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Angela Granata, Geoffroy Venton, Claude Lemarie, Diane Coso, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, Norbert Vey, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3031.

https://doi.org/10.1182/blood.V120.21.3031.3031

Published: 2012

Journal Articles

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Jean El-Cheikh, MD PhD, Raynier Devillier, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Boris Calmels, Catherine Faucher, Anne Marie Stoppa, MD, Angela Granata, Claire Oudin, Patrick Ladaique, Claude Lemarie, Geoffroy Venton, Reda Bouabdallah, MD, Christine Zandotti, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4496.

https://doi.org/10.1182/blood.V120.21.4496.4496

Published: 2012

Journal Articles

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

Jean El-Cheikh, MD PhD, Geoffroy Venton, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Catherine Faucher, Angela Granata, Claire Oudin, Reda Bouabdallah, MD, Norbert Vey, MD, Segolene Duran, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4505.

https://doi.org/10.1182/blood.V120.21.4505.4505

Published: 2012

Journal Articles

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Sabine Furst, MD, Reda Bouabdallah, MD, Diane Coso, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Angela Granata, Claire Oudin, Geoffroy Venton, Anne Marie Stoppa, Claude Lemarie, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4526.

https://doi.org/10.1182/blood.V120.21.4526.4526

Published: 2012

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity

Lara Crucitti, MS, Luca Vago, MD PhD, Roberto Crocchiolo, MD PhD, Cristina Toffalori, MSc, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Matteo Carrabba, MD, Benedetta Mazzi, BSc, Elisabetta Zino, BSc, Sarah Marktel, MD, Magda Marcatti, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD

Blood (2012) 120 (21): 1957.

https://doi.org/10.1182/blood.V120.21.1957.1957

Published: 2012

Journal Articles

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Geoffroy Venton, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Sabine Furst, MD, Angela Granata, Claire Oudin, Catherine Faucher, Diane Coso, MD, Reda Bouabdallah, MD, Pierre Berger, Norbert Vey, Patrick Ladaique, Christian Chabannon, MD, PhD, Michele Merlin, Didier Blaise, MD

Blood (2012) 120 (21): 4186.

https://doi.org/10.1182/blood.V120.21.4186.4186

Published: 2012

NARROW

Current IST-Free/Relapse-Free Survival As a Surrogate Estimate of OS after Allotransplant for Acute Leukemia

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients

Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in High Risk Haematological Diseases: A 10-Years Evaluation at San Raffaele Scientific Institute

Higher Prevalence But Similar Infectious Profile Overtime After Haploidentical Transplantation Compared With HLA-Identical Transplantation For Hematological Diseases

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Lower Relapse and Better PFS Among Chemosensitive Patients Undergoing Allogeneic Transplantation By Haploidentical Compared With HLA-Identical DONOR: Results On A Cohort Of 94 Patients With Hodgkin’S Lymphoma

Bone Marrow (BM) Versus Peripheral Blood Stem Cell (PBSC) For Haploidentical Transplantation With Nonmyeloblative (NMA) Conditioning Regimen and Post Infusion Cyclophosphamide

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only